chr11-108306811-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000051.4(ATM):​c.5675-1086C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.547 in 152,076 control chromosomes in the GnomAD database, including 23,163 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.55 ( 23163 hom., cov: 32)

Consequence

ATM
NM_000051.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.53

Publications

16 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.632 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.5675-1086C>T
intron
N/ANP_000042.3
ATM
NM_001351834.2
c.5675-1086C>T
intron
N/ANP_001338763.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.5675-1086C>T
intron
N/AENSP00000501606.1
ATM
ENST00000452508.7
TSL:1
c.5675-1086C>T
intron
N/AENSP00000388058.2
ATM
ENST00000527805.6
TSL:1
n.*739-1086C>T
intron
N/AENSP00000435747.2

Frequencies

GnomAD3 genomes
AF:
0.547
AC:
83101
AN:
151958
Hom.:
23149
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.447
Gnomad AMI
AF:
0.643
Gnomad AMR
AF:
0.628
Gnomad ASJ
AF:
0.652
Gnomad EAS
AF:
0.434
Gnomad SAS
AF:
0.650
Gnomad FIN
AF:
0.630
Gnomad MID
AF:
0.756
Gnomad NFE
AF:
0.569
Gnomad OTH
AF:
0.578
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.547
AC:
83144
AN:
152076
Hom.:
23163
Cov.:
32
AF XY:
0.554
AC XY:
41187
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.447
AC:
18523
AN:
41456
American (AMR)
AF:
0.628
AC:
9600
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.652
AC:
2262
AN:
3470
East Asian (EAS)
AF:
0.434
AC:
2243
AN:
5166
South Asian (SAS)
AF:
0.651
AC:
3140
AN:
4824
European-Finnish (FIN)
AF:
0.630
AC:
6669
AN:
10590
Middle Eastern (MID)
AF:
0.748
AC:
220
AN:
294
European-Non Finnish (NFE)
AF:
0.569
AC:
38678
AN:
67970
Other (OTH)
AF:
0.579
AC:
1225
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1920
3840
5760
7680
9600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
718
1436
2154
2872
3590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.565
Hom.:
63478
Bravo
AF:
0.539
Asia WGS
AF:
0.574
AC:
1997
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.38
DANN
Benign
0.48
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs599558; hg19: chr11-108177538; API